Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

KuQuinones Equilibria Assessment for Biomedical Applications.

Sabuzi F, Lentini S, Sforza F, Pezzola S, Fratelli S, Bortolini O, Floris B, Conte V, Galloni P.

J Org Chem. 2017 Oct 6;82(19):10129-10138. doi: 10.1021/acs.joc.7b01602. Epub 2017 Sep 18.

PMID:
28872314
2.

Synthesis and structure--activity relationship of new cytotoxic agents targeting human glutathione-S-transferases.

Rotili D, De Luca A, Tarantino D, Pezzola S, Forgione M, Morozzo Della Rocca B, Falconi M, Mai A, Caccuri AM.

Eur J Med Chem. 2015 Jan 7;89:156-71. doi: 10.1016/j.ejmech.2014.10.033. Epub 2014 Oct 13.

PMID:
25462236
3.

Selective inhibition of miR-92 in hippocampal neurons alters contextual fear memory.

Vetere G, Barbato C, Pezzola S, Frisone P, Aceti M, Ciotti M, Cogoni C, Ammassari-Teule M, Ruberti F.

Hippocampus. 2014 Dec;24(12):1458-65. doi: 10.1002/hipo.22326. Epub 2014 Jul 17.

PMID:
24990518
4.

A lentiviral sponge for miR-101 regulates RanBP9 expression and amyloid precursor protein metabolism in hippocampal neurons.

Barbato C, Pezzola S, Caggiano C, Antonelli M, Frisone P, Ciotti MT, Ruberti F.

Front Cell Neurosci. 2014 Feb 13;8:37. doi: 10.3389/fncel.2014.00037. eCollection 2014.

5.

Targeting GSTP1-1 induces JNK activation and leads to apoptosis in cisplatin-sensitive and -resistant human osteosarcoma cell lines.

Sau A, Filomeni G, Pezzola S, D'Aguanno S, Tregno FP, Urbani A, Serra M, Pasello M, Picci P, Federici G, Caccuri AM.

Mol Biosyst. 2012 Apr;8(4):994-1006. doi: 10.1039/c1mb05295k. Epub 2011 Nov 9.

PMID:
22068640
6.

Role of glutathione transferases in the mechanism of brostallicin activation.

Pezzola S, Antonini G, Geroni C, Beria I, Colombo M, Broggini M, Marchini S, Mongelli N, Leboffe L, MacArthur R, Mozzi AF, Federici G, Caccuri AM.

Biochemistry. 2010 Jan 12;49(1):226-35. doi: 10.1021/bi901689s. Erratum in: Biochemistry. 2010 Jun 15;49(23):4930. Marchini, Sergio [added].

PMID:
19950984
7.

Structural basis for the binding of the anticancer compound 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol to human glutathione s-transferases.

Federici L, Lo Sterzo C, Pezzola S, Di Matteo A, Scaloni F, Federici G, Caccuri AM.

Cancer Res. 2009 Oct 15;69(20):8025-34. doi: 10.1158/0008-5472.CAN-09-1314. Epub 2009 Oct 6.

8.

In vitro and in vivo efficacy of 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) on human melanoma.

Pellizzari Tregno F, Sau A, Pezzola S, Geroni C, Lapenta C, Spada M, Filomeni G, Bonanno E, Federici G, Caccuri AM.

Eur J Cancer. 2009 Sep;45(14):2606-17. doi: 10.1016/j.ejca.2009.06.033. Epub 2009 Aug 6.

PMID:
19665369
9.

The glutathione S-transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol overcomes the MDR1-P-glycoprotein and MRP1-mediated multidrug resistance in acute myeloid leukemia cells.

Ascione A, Cianfriglia M, Dupuis ML, Mallano A, Sau A, Pellizzari Tregno F, Pezzola S, Caccuri AM.

Cancer Chemother Pharmacol. 2009 Jul;64(2):419-24. doi: 10.1007/s00280-009-0960-6. Epub 2009 Mar 15.

PMID:
19288261
10.
11.

6-(7-Nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol, a specific glutathione S-transferase inhibitor, overcomes the multidrug resistance (MDR)-associated protein 1-mediated MDR in small cell lung cancer.

Filomeni G, Turella P, Dupuis ML, Forini O, Ciriolo MR, Cianfriglia M, Pezzola S, Federici G, Caccuri AM.

Mol Cancer Ther. 2008 Feb;7(2):371-9. doi: 10.1158/1535-7163.MCT-07-0487.

Supplemental Content

Loading ...
Support Center